EPISODE · Jan 27, 2023 · 44 MIN
Dr. Steven Pipe on HEMGENIX, hemophilia B's first gene therapy
from BloodStream
We've got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode! Show Notes: Subscribe: The BloodStream Podcast Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more. Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook BloodStream on Twitter
Embed this episode
Ready to play
Dr. Steven Pipe on HEMGENIX, hemophilia B's first gene therapy
No transcript for this episode yet
Similar Episodes
No similar episodes found.